Peter DiLaura

Chief Executive Officer @ Helicore Biopharma

About

An accomplished biotechnology executive with over 25 years of experience in the life sciences industry. Driven by a passion for building great teams capable of break-through innovation.

Country

United States

City

San Francisco

Industry

Biotechnology

Skill

Board Governance, Biotechnology, Life Sciences, Strategy, Business Development, Drug Discovery, Start-ups, Pharmaceutical Industry, Mergers & Acquisitions, Strategic Planning, Product Management, Big Data, Microbiome, Management, Lifesciences, Venture Capital, Commercialization, Marketing, Strategic Consulting, Public Speaking

Experience

Chief Executive Officer

Helicore Biopharma

2025-12 - Present · 10 mos

Independent Board Director

Weave Bio

2026-1 - Present · 9 mos

Independent Board Director

Character Biosciences

2020-1 - Present · 6 yrs 9 mos

San Francisco Bay Area

Strategic Advisor, Engineering Health Portfolio

Innovation Endeavors

2024-2 - Present · 2 yrs 8 mos

President and CEO

Initial Therapeutics

2024-4 - 2025-8 · 1 yr 5 mos

South San Francisco, California, United States

Strategic Advisor

Sonoma Biotherapeutics, Inc.

2024-4 - 2025-4 · 1 yr 1 mo

Chief Business and Strategy Officer

Sonoma Biotherapeutics, Inc.

2020-2 - 2024-4 · 4 yrs 3 mos

Member of the Executive Team, responsible for all elements of company operations and strategy, including financing, corporate development and partnering, financial operations, program and portfolio management, legal, and HR. - Led financing efforts, including $265M Series B financing - Led corporate development efforts, including principal sourcing and negotiation of multi-indication discovery, development, and commercialization collaboration with Regeneron, with $75M upfront, $45M in early milestones, and 50/50 cost and profit sharing structure - Built and managed Finance, Legal, HR, and Program Management functions

Entrepreneur In Residence

Third Rock Ventures

2018-1 - 2020-1 · 2 yrs 1 mo

San Francisco Bay Area

Led and supported incubation efforts for multiple early company concepts.

Strategic Advisor

SV Health Investors' Dementia Discovery Fund (DDF)

2017-9 - 2019-12 · 2 yrs 4 mos

Greater Boston Area

Advisor

Takeda

2017-1 - 2017-12 · 1 yr

President & CEO

Second Genome Inc.

2010-11 - 2016-4 · 5 yrs 6 mos

South San Francisco, CA

CEO and Director of Second Genome, a South San Francisco biotechnology company developing novel drugs from microbiome science. Led the company from an early team of founders to 30 employees.